Entity family

Browse funders

Organisations named as supporting, sponsoring, or funding research. Examples include Wellcome, NIHR, research councils.

2articles mentioning funders

2funder mentions

1distinct funders extracted

0%of mentions human-reviewed

Active filtersEntity: Vivli ×

Vivli

This funder is selected. Its supporting articles are shown below.

Articles mentioning Vivli

2 articles · page 1 of 1

PT7:02 Discordance between SLEDAI-2K and BILAG-2004 disease activity classification leads to divergent treatment decisions under EULAR 2023 recommendations: a post-hoc analysis of anifrolumab trials

lupusscimed · abstract · 2026-03-01 · 1 matching annotations

83.3%

AstraZeneca Vivli Vivli,Inc SLE lupus SLE-DAS anifrolumab BILAG-2004 EQ-5D SLEDAI-2K

…lication is based on research using data from data contributors AstraZeneca that has been made available through Vivli,Inc. Vivli has not c…

S13:01 The novel SLE-DAS responder index aligns clinical endpoints with patient experience and outperforms BICLA and SRI-4 in capturing HRQoL: post-hoc analysis in the MUSE, TULIP-1 and TULIP-2 trials

lupusscimed · abstract · 2026-03-01 · 1 matching annotations

80.8%

AstraZeneca Vivli Vivli, Inc SLE SLE-DAS anifrolumab MSDA

…lication is based on research using data from data contributors AstraZeneca that has been made available through Vivli, Inc. Vivli has not …